|
11 Nov 2019 |
Social |
RT @DrPetryna: #ACR19 @rheumnow abs1913 Cohort study confirms the association of HLA-B*15 with peripheral joint involvement in AS but not i… |
|
|
11 Nov 2019 |
Social |
RT @philipcrobinson: Nice data in r-axSpA treated with ixekizumab showing improvements in fatigue, pain and sleep #ACR19 @RheumNow Abs 1510… |
|
|
11 Nov 2019 |
Social |
RT @EBRheum: Abst#1501 - 52w data for IXE in AxSpa, #ACR19 @RheumNow
Take open label follow up with a grain of salt, but good to see pers… |
|
|
11 Nov 2019 |
Social |
RT @DrPetryna: #ACR19 @rheumnow ABS1481 Corrona PsA/SpA Registy: real-world use of Apremilast +biologics happens mostly in pts who received… |
|
|
11 Nov 2019 |
Social |
RT @DrPetryna: Do you feel comfortable combining apremilast with biologics in refractory/difficult to treat PsA patients ? |
|
|
11 Nov 2019 |
ACR Video |
Gender Differences in Ankylosing Spondylitis: Dr. Torkell Juulsgaard |
|
|
11 Nov 2019 |
Social |
RT @uptoTate: Small study suggests subclinical inflammation detected by MRI in joints of hand in PsA patients in MDA. Abst #1171 #ACR19 #AC… |
|
|
11 Nov 2019 |
Social |
RT @synovialjoints: Does anti-TNF treatment halt radiographc progression in ankylosing spondylitis? #ACR19 @RheumNow Vote here |
|
|
11 Nov 2019 |
Social |
RT @DrKanikaMonga: What a pleasant surprise to be included in the #axSpA poster tour today — my research - showing an association with wor… |
|
|
10 Nov 2019 |
Social |
RT @DrKanikaMonga: Woo hoo! @rheum_cat and her poster on CV disease risk in aXSpA abstr #622 #ACR19 https://t.co/eaDyCKZs5J |
|
|
07 Nov 2019 |
News |
Most Psoriatics Go on Biologics |
|
|
05 Nov 2019 |
News |
Year in Review - Psoriatic Arthritis 2019 |
|
|
04 Nov 2019 |
Social |
Cancer Risk with psoriasis? Metanalysis of 58 studies shows that PSO is associated with an 18-22% increased risk of all cancers, highest w/ severe PSO. Increased risk of colon, laryngeal, liver, lymphoma/NHL, esophageal, oral cavity & pancreatic CA https://t.co/HYOej7mrbQ |
|
|
04 Nov 2019 |
News |
EXCEED Study: Cosentyx Equals Humira in Psoriatic Arthritis |
|
|
01 Nov 2019 |
News |
Rinvoq (upadacitinib) Effective in Psoriatic Arthritis |
|
|
01 Nov 2019 |
Social |
Data on 14 261 PsA patients (from 11 European registries) startin TNFi therapy - shows that half (56%) were in DAS28 remission and 53% were ACR20 responders after 6 months, and 3/4 were still on TNFi at 1 year https://t.co/RIHVjyJ7bn |
|
|
01 Nov 2019 |
Social |
Study of 1810 AS pts from British registry on ankylosing spondylitis (BSRBR-AS) finds lower quality of life in AS is due to disease activity, depression, sleep disturbance, activity impairment, fibromyalgia, Widespread Pain, and tobacco smoking https://t.co/m0oG156CgY |
|
|
31 Oct 2019 |
Social |
Claims analysis of psoriasis & PsA treated with inhibitors of TNF , IL-17 (SEC, IXE) or IL12/23 (UST) (2015-18) shows 2% of biologic starts had serious infections. SIE rates equal for TNFi & IL-17i; but were lower for IL-12/23 vs TNFi (HR=0.59; 0.39 -.90) https://t.co/YbNmEe19tS |
|
|
31 Oct 2019 |
Social |
Swedish study of comorbidities compared 982 Psoriatic arthritis patients to the general population, finding PsA pts had higher rates of Obesity (BMI ≥ 30) (28.6% vs 16.3%), HTN (40.3% vs 24.1%) & diabetes (10.5% vs 6.2%). https://t.co/fFQ1almeJR |
|
|
29 Oct 2019 |
Social |
Study of 238 PsA patients starting a biologic shows that comparing those w/ comorbid FM vs without, PsA pts with FM had lower biologic survival (50% vs 74%) and PsA-FM unlikely to achieve remission (3.4% at 3mos and 0% at 6 months). https://t.co/29RAIEtGZA |
|
